Genetic Skin Diseases
Introduction
Genetic skin diseases are caused by the transmission of abnormal or mutated genes from parents to their offspring, leading to specific skin lesions that appear at birth or later in life. Over a hundred types of genetic skin diseases are known, including freckles, ichthyosis, and albinism.
Why Choose China
Advanced Technologies
With the advancement of technology in China, screening and diagnostic techniques for neonatal genetic diseases have seen significant leaps, particularly with the application of Next-Generation Sequencing (NGS) technology, greatly enhancing clinical efficiency and accuracy. Chinese doctors have also accumulated extensive experience, making significant progress in the treatment of genetic skin diseases.
Experienced Doctors
China has made significant strides in ex vivo gene modification therapy, which involves genetically modifying a patient’s own cells outside the body and then reintroducing them, providing a long-term functional gene/protein expression and supporting wound healing . This strategy has been successfully applied to conditions such as junctional epidermolysis bullosa (JEB) and recessive dystrophic epidermolysis bullosa (RDEB), offering a life-saving therapy for patients with complete epidermal loss . China’s commitment to precision medicine and its ability to culture and manipulate keratinocytes, including stem cells, ex vivo has led to the development of genetically modified epidermal sheet therapies, which have shown remarkable results in restoring skin function and structure . These advancements position China as a leader in the field of genetic skin disease treatment, offering novel and effective solutions for patients suffering from these conditions.
Honors
At the 25th World Congress of Dermatology in 2023, Professor Lu Qianjin, Chairman of the 15th Committee of the Dermatology and Venereology Branch of the Chinese Medical Association and a professor at Xiangya Hospital of Central South University, was successfully elected as an executive director of the International League of Dermatological Societies (ILDS). ILDS is one of the most authoritative dermatological organizations globally, with its board composed of distinguished experts in dermatology from around the world. This honor not only recognizes Professor Lu Qianjin’s academic achievements but also acknowledges the international standing of Chinese dermatological research. It is expected that in future world-class conferences, we will hear more Chinese voices, and China will contribute significantly to the development and prosperity of global dermatology.
Genetic Skin Diseases
Introduction
Genetic skin diseases are caused by the transmission of abnormal or mutated genes from parents to their offspring, leading to specific skin lesions that appear at birth or later in life. Over a hundred types of genetic skin diseases are known, including freckles, ichthyosis, and albinism.
Why Choose China
Advanced Technologies
With the advancement of technology in China, screening and diagnostic techniques for neonatal genetic diseases have seen significant leaps, particularly with the application of Next-Generation Sequencing (NGS) technology, greatly enhancing clinical efficiency and accuracy. Chinese doctors have also accumulated extensive experience, making significant progress in the treatment of genetic skin diseases.
Experienced Doctors
China has made significant strides in ex vivo gene modification therapy, which involves genetically modifying a patient’s own cells outside the body and then reintroducing them, providing a long-term functional gene/protein expression and supporting wound healing . This strategy has been successfully applied to conditions such as junctional epidermolysis bullosa (JEB) and recessive dystrophic epidermolysis bullosa (RDEB), offering a life-saving therapy for patients with complete epidermal loss . China’s commitment to precision medicine and its ability to culture and manipulate keratinocytes, including stem cells, ex vivo has led to the development of genetically modified epidermal sheet therapies, which have shown remarkable results in restoring skin function and structure . These advancements position China as a leader in the field of genetic skin disease treatment, offering novel and effective solutions for patients suffering from these conditions.
Honors
At the 25th World Congress of Dermatology in 2023, Professor Lu Qianjin, Chairman of the 15th Committee of the Dermatology and Venereology Branch of the Chinese Medical Association and a professor at Xiangya Hospital of Central South University, was successfully elected as an executive director of the International League of Dermatological Societies (ILDS). ILDS is one of the most authoritative dermatological organizations globally, with its board composed of distinguished experts in dermatology from around the world. This honor not only recognizes Professor Lu Qianjin’s academic achievements but also acknowledges the international standing of Chinese dermatological research. It is expected that in future world-class conferences, we will hear more Chinese voices, and China will contribute significantly to the development and prosperity of global dermatology.